In this study, we sought to assess the relationship between AD pathologies (tau and amyloid) or small vessel disease (SVD) markers (lacunes and WMH) and WM structural connectivity in patients with EOAD and LOAD. The gene discussed is MAPT; the disease is Alzheimer disease.